While the renal benefits of oral semaglutide vs placebo in the SOUL trial didn't match the effects seen with the injectable ...

From Meta, OpenAI, Google, and Databricks to Nvidia and Samsung, numerous new AI capabilities have been announced ...

Hypertension treatment and the role of cortisol in cardio-renal-metabolic health were among the featured topics from this ...

AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging field of treatments that can reprogramme immune cells inside patients ...

The global diabetic nephropathy market revenue was around US$ 2.0 billion in 2022 and is estimated to reach US$ 3.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 6% during the ...

Two impressive studies in lung cancer and another in breast cancer made Sunday a stellar day for AstraZeneca at the ASCO congress. Three of the group’s top cancer drugs were on display – EGFR ...

It has been assumed that β-AR antagonists (β-blockers) have a direct favorable influence on the heart, but our results challenge this view, suggesting that β-blockers may also act directly in ...